Healthcare / PharmaceuticalsUpdated 2026-05-10 22:07 UTC

PSX/GLAXO stock hub

PSX/GLAXO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PSX/GLAXOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

116.1B

Pakistan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

PSX/GLAXO

In the news

Latest news · PSX/GLAXO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.7

P25 9.7P50 11.8P75 12.4

Trailing P/E11

P25 11.3P50 13.1P75 16.5

ROE31.5

P25 13.5P50 23.8P75 30.1

ROIC39.1

P25 11.2P50 16.7P75 31.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PSX/GLAXO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

PKR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Pakistan
Country code	PK
Employees	1,606
Employees Change	-94%
Employees Change Percent	-5.53
Enterprise value	PKR 106.6B
Exchange	Pakistan Stock Exchange
Financial currency	PKR
First seen	2026-05-10
Industry	Pharmaceuticals
Isin	PK0001301016
Last refreshed	2026-05-10
Market cap	PKR 116.1B
Price	PKR 365
Price currency	PKR
Rev Per Employee	41,935,919.05x
Sector	Healthcare
Sic	2834
Symbol	psx/GLAXO
Website	https://www.pk.gsk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.05%
EV Earnings	10.14x
EV/EBIT	6.26x
EV/EBITDA	5.78x
EV/FCF	13.74x
EV/Sales	1.58x
FCF yield	6.68%
Forward P/E	9.67x
P/B ratio	3.2x
P/E ratio	11.05x
P/S ratio	1.72x
PE Ratio10 Y	17.33x
PE Ratio3 Y	20.23x
PE Ratio5 Y	16.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.3%
EBITDA Margin	27.29%
FCF margin	11.52%
Gross margin	37.63%
Gross Profit	PKR 25.3B
Gross Profit Growth	38.26%
Gross Profit Growth Q	19.86%
Gross Profit Growth3 Y	59.79%
Gross Profit Growth5 Y	26.02%
Net Income	PKR 10.5B
Net Income Growth	29.79%
Net Income Growth Q	22.77%
Net Income Growth3 Y	74.78%
Net Income Growth5 Y	23.38%
Pretax Margin	25.91%
Profit Margin	15.6%
Profit Per Employee	PKR 6.5M
ROA	20.73
Roa5y	12.98
ROCE	44.68
ROE	31.52
Roe5y	20.12
ROIC	39.14
Roic5y	26.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.14%
Cagr15y	17.22%
Cagr1y	8.93%
Cagr20y	12.31%
Cagr3y	70.61%
Cagr5y	22.81%
Div CAGR10	15.57%
Div CAGR3	34.42%
Div CAGR5	21.2%
EPS Growth	29.79
EPS Growth Q	22.8
EPS Growth3 Y	74.78
EPS Growth5 Y	23.38
FCF Growth	206.14%
FCF Growth5 Y	15.5%
OCF Growth	105.56%
OCF Growth Q	1,546.58%
OCF Growth10 Y	12.08%
OCF Growth5 Y	15.26%
Revenue Growth	10.14x
Revenue Growth Q	9.3x
Revenue Growth3 Y	14.71x
Revenue Growth5 Y	14.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PKR 1.31
Assets	PKR 54B
Cash	PKR 9.9B
Current Assets	PKR 38.5B
Current Liabilities	PKR 15.9B
Debt	PKR 355.1M
Debt EBITDA	PKR 0.02
Debt Equity	PKR 0.01
Debt FCF	PKR 0.05
Equity	PKR 36.3B
Liabilities	PKR 17.7B
Long Term Assets	PKR 15.5B
Long Term Liabilities	PKR 1.8B
Net Cash	PKR 9.6B
Net Cash By Market Cap	PKR 8.23
Net Cash Growth	64.08%
Net Debt EBITDA	PKR -0.52
Net Debt Equity	PKR -0.26
Net Debt FCF	PKR -1.23
Tangible Book Value	PKR 35.3B
Tangible Book Value Per Share	PKR 111
WACC	6.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.43
Inventory Turnover	3.11
Net Working Capital	PKR 12.8B
Quick ratio	1.44
Working Capital	PKR 22.6B
Working Capital Turnover	PKR 3.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	70%
Dividend Growth Years	3%
Dividend per share	PKR 17
Dividend Years	2
Dividend Yield	4.66%
Ex Div Date	2026-04-24
Last Dividend	PKR 12
Payout Frequency	Semi-Annual
Payout Ratio	45.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	139.85%
1Y total return	8.92%
200-day SMA	395.6
3Y total return	396.81%
50-day SMA	345.6
50-day SMA vs 200-day SMA	50under200
5Y total return	179.36%
All Time High	481
All Time High Change	-24.19%
All Time High Date	2025-04-14
All Time Low	7.78
All Time Low Change	4,585.68%
All Time Low Date	1999-02-23
ATR	15.09
Beta	0.41
Beta1y	1.03
Beta2y	0.55
Ch YTD	-6.45
High	367.1
High52	459.9
High52 Date	2025-09-23
High52ch	-20.72%
Low	362
Low52	293.1
Low52 Date	2026-03-09
Low52ch	24.41%
Ma50ch	5.49%
Price vs 200-day SMA	-7.82%
RSI	52.76
RSI Monthly	56.23
RSI Weekly	45.87
Sharpe ratio	0.58x
Sortino ratio	1.08
Total Return	4.66%
Tr YTD	-3.42
Tr15y	984.48%
Tr1m	16.15%
Tr1w	7.58%
Tr3m	-9.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PKR 17B
Operating Income Growth	31.92
Operating Income Growth Q	19.1
Operating Income Growth3 Y	51.34
Operating Income Growth5 Y	26.62
Operating margin	25.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,211,881%
Net Borrowing	-65,518,000
Shares Insiders	0%
Shares Institutions	6.4%
Shares Out	318,467,278
Shares Qo Q	-0.03%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PKR 7.8B
Average Volume	343,303.5x
Bv Per Share	114
CAPEX	PKR -2.5B
Ch10y	76.07
Ch15y	571.5
Ch1m	12.51
Ch1w	7.58
Ch1y	4.23
Ch20y	379.2
Ch3m	-12.17
Ch3y	365
Ch5y	148.5
Ch6m	-8.47
Change	-1.2%
Change From Open	-0.17
Close	369.1
Days Gap	-1.03
Depreciation Amortization	1,339,455,250
Dollar Volume	53,330,423.2
Earnings Date	2026-04-27
EBIT	PKR 17B
EBITDA	PKR 18.4B
EPS	PKR 33
F Score	5
FCF	PKR 7.8B
FCF EV Yield	7.28x
FCF Per Share	PKR 24.35
Financing CF	-4,808,650,000
Fiscal Year End	December
Founded	2,001
Goodwill	955,742,000
Graham Number	290.89585
Graham Upside	-20.22
Income Tax	PKR 6.9B
Investing CF	-1,680,560,000
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2014-04-18
Last Split Type	Forward
Lynch Fair Value	PKR 772
Lynch Upside	111.6
Ma150	386.5
Ma150ch	-5.66%
Ma20	368.3
Ma20ch	-0.99%
Net CF	3,722,294,000
Next Earnings Date	2026-08-24
Open	365.3
P FCF Ratio	14.97
P OCF Ratio	11.37
Payment Date	2026-05-06
Position In Range	51.76
Ppne	14,385,837,000
Price Date	2026-05-08
Price EBITDA	PKR 6.32
Ptbv Ratio	3.29
Relative Volume	0.43x
Revenue	67,349,086,000x
Tax By Revenue	10.31x
Tax Rate	39.78%
Tr20y	919.96%
Tr6m	-5.5%
Volume	146,255
Z Score	7.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

PSX/GLAXO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.7%

$17.0 annual per share

Payout ratio

+45.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+21.2%

3 consecutive years of growth

Total shareholder yield

+4.7%

Next ex-dividend date: 2026-04-24

Performance

PSX/GLAXO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PSX/GLAXO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Share of float held by funds and institutions

Insider ownership

0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

PSX/GLAXO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.8

Neutral momentum band

Price vs 200-day MA

-7.8%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PSX/GLAXO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current psx/GLAXO stock rating?

psx/GLAXO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full psx/GLAXO analysis?

The full report lives at /stocks/psx/GLAXO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for psx/GLAXO?

The latest report frames psx/GLAXO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the psx/GLAXO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.